ACTRN12615000794505已完成4 期
In persons receiving treatment with zoledronic acid for fracture prevention or Paget's disease, does the administration of oral dexamethasone, compared to placebo, reduce the incidence of acute phase response?
Bone & Joint Research Group, University of Auckland0 个研究点目标入组 40 人开始时间: 2015年7月30日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 o limit（—）
- 性别
- All
入选标准
- •Females or males aged 20 or older.
- •Prescribed zoledronic acid for the first time for fracture prevention or Paget's disease.
排除标准
- •Prior treatment with zoledronic acid.
- •History of fever, infection, or influenza-like illness within the past week.
- •Diabetes mellitus or uncontrolled hypertension (BP >160/90)
- •Treatment with glucocorticoids within the past week.
- •History of adverse reaction to glucocorticoids.
- •Major systemic illness, including malignancy.
研究者
相似试验
已完成
Unknown
A new study to minimise the side effects of rapid maxillary expansioSide effects of rapid maxillary expansion (RME) on dental and buccal alveolar bone changesOral HealthISRCTN16744226Damascus University32
已完成
不适用
Zoledronic acid injection prevents bone loss in spinal cord injury patientsCTRI/2018/03/012408Dr Satyaranjan Sethi60
已完成
2 期
Phase II study of zoledronic acid concomitant with androgen deprivation therapy for patients with treatment-naive bone-metastatic prostate cancerProstate cancerJPRN-UMIN000007548Kinki University52
招募中
2 期
A phase II clinical trial of zoledronic acid treatment for advanced non-small cell lung cancer with bone metastasis.on-small cell lung cancerJPRN-UMIN000006935Dokkyo Medical University School of Medicine, Department of Pulmonary Medicine and Clinical Immunology40
进行中（未招募）
不适用
A multi-centre, randomised studyof Zoledronic Acid versus Observationin Patients with Asymptomatic Myeloma - NDEUCTR2006-003854-33-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI